Itraconazole is an ergosterol biosynthesis inhibitor in many fungi (18, (20) (21) (22) . This triazole antifungal agent has been shown to inhibit the cytochrome P-450-dependent 14a-demethylation of lanosterol or 24-methylene-24,25-dihydrolanosterol (eburicol) in, for example, Candida albicans, Candida glabrata, Candida lusitaniae, Aspergillus fumigatus, Trichophyton mentagrophytes, and Histoplasma capsulatum. In all these fungi, the interaction of itraconazole with the 14a-demethylase results in a decreased availability of ergosterol and a concomitant accumulation of a variety of 14a-methylsterols. For example, complete inhibition of ergosterol synthesis was achieved in C. albicans after 1 h of contact with itraconazole concentrations as low as 10 nM (21) . After 24 h of incubation, ergosterol synthesis was completely blocked at 30 nM (18) , and, at 300 nM ergosterol, concentrations decreased below the detection level, i.e., < 5 fg per cell (20) .
Ergosterol has an essential regulatory function in processes of cell proliferation (1) . Furthermore, ergosteroldepleted membranes are more permeable to glucose and other small polar molecules and ions (7) and a number of 14-methylated sterols impair membrane functions and affect membrane-bound enzymes (17) . Thus, the itraconazoleinduced inhibition of the 14a-demethylase is at the origin of a cascade of perturbations which together lead to the gross antifungal activity of this triazole derivative.
In vitro and in vivo data document the high activity of itraconazole against Cryptococcus neoformans (2) . So far, sterol synthesis in this yeast has not been studied. In this article, we prove that ergosterol is the main sterol synthesized by C. neofonnans and present evidence to suggest that itraconazole's activity against C. neoformans originates from its interaction with the 14a-demethylation of eburicol and (directly or indirectly) with the final step in the 4-demethylation reaction.
MATERIALS AND METHODS
Culture methods. The C. neofornans var. neoformans isolate (B42419; ATCC 32265) was maintained on Sabouraud agar slants at 37°C. A loopful from a 24-h slant was inoculated in Sabouraud broth and incubated for 48 h at 37°C. A 0.2-ml sample from this culture was used to inoculate a 500-ml Erlenmeyer flask filled with 100 ml of PYG medium containing polypeptone, yeast extract, and glucose (each at 1 g/liter), and the mixture was incubated for 24 h at 37°C in a reciprocating shaker (100 strokes per min). To study the effects of itraconazole (R 51 211; Janssen Pharmaceutica) on growth, volumes of 0.2 ml of the 24-h culture were used to inoculate 500-ml Erlenmeyer flasks with 100 ml of PYG medium. Itraconazole and/or dimethyl sulfoxide (DMSO) was added to the medium before inoculation. After 16 h of growth at 37°C in a reciprocating shaker, the total number of cells was counted with a Coulter Counter (25 Hewlett-Packard), using helium as a carrier gas at a flow rate of 1 ml/min. The column temperature was programmed at 12°C/min (initial temperature, 50°C; final temperature, 310°C). The transfer line temperature was 320°C; the ion source temperature was kept at 180°C. The electron energy was maintained at 73 eV, and the emission current was maintained at 300 ,uA.
Protein content. The protein contents of the homogenates were determined by the Bio-Rad method, with bovine albumin used as the standard.
RESULTS
Effects of itraconazole on growth. The results summarized in Fig. 1 that corresponded with those of ergosterol (4, 13, 25) . The structures of the sterols are shown in Fig. 2 . Analysis by GC of the second HPLC fraction (retention time relative to that of ergosterol, 1.76) revealed two equal peaks. The mass spectra of these sterols were identical to those reported for ergosta-7,22-dien-3-ol and ergosta-5,7-dien-3-ol (13) . The molecular ion and fragmentation patterns of the sterol present in the third HPLC fraction (relative retention time, 1.29) were in agreement with that reported for ergosta-7-en-3,-ol (fungisterol) (13) .
Effects of itraconazole on ergosterol synthesis. After 16 h of growth of C. neoformans in PYG medium supplemented with [14C]acetate and increasing concentrations of itraconazole 50% inhibition of ergosterol synthesis was achieved at 6.0 ± 4.7 nM (means ± standard deviations of six experiments); complete inhibition was reached at approximately 100 nM (Fig. 3) . Inhibition of ergosterol synthesis coincided with up to 1 ,uM itraconazole, with a concentration-dependent increased incorporation of radioactivity into the extract containing sterols plus squalene (Fig. 3) . The HPLC analysis indicated that this increased radioactivity was mainly due to the accumulation of a sterol with the same relative retention time (1.59) as eburicol (Fig. 3, fraction C) .
In addition to ergosterol and eburicol, two minor sterol fractions were present (Fig. 3, fractions A and B) . The relative retention times were 1.16 and 1.29, respectively. In some experiments, trace amounts only of 14a-methyl-ergosta-8,24(28)-dien-33,6a-diol were found (results not shown); 14a-methyl-ergosta-5,7,22,24(28)-tetraenol, 14a-methylfecosterol, and lanosterol were not detected. The incorporation of radioactivity into the squalene fraction increased with increasing concentrations of itraconazole, as in HPLC fractions B and C (Fig. 3) .
To identify further the nature of the sterols present, HPLC fractions A to C were separated from the sterol extracts from C. neoformans grown for 16 h in the presence of 10 nM ANTimICROB. AGEN-rs C14EMOTHER. itraconazole and analyzed by GC-mass spectrometry. HPLC fraction A contained 2 sterols for which the mass spectra were identical to those of ergosta-5,7-dien-3-ol (13) and 14a-methyl-ergosta-8,24(28)-dien-3-one (14a-methylfecosterone) (6) . GC analysis of fraction B also showed two components: the mass spectrum of the first (approximately 15%) was identical to that of ergosta-7-en-30-ol (13) , and that of the second (approximately 85%) was in agreement with the spectrum reported for obtusifoliol (4, 12, 25 (12, 25) .
To study further the effects of increasing concentrations of itraconazole on the accumulation of obtusifolione, a second HPLC system was used that separated the 3-ketosteroid from eburicol. Both were identified according their relative retention times (1.33 and 1.69 min) and by GC-mass spectrometry. As shown in Fig. 4 , itraconazole induced a concentration-dependent accumulation of obtusifolione. At a concentration of itraconazole of 100 nM, more obtusifolione than eburicol accumulated. The increased synthesis of obtusifolione is at least partially responsible for the increased accumulation of radioactivity into the sterol-plus-squalene extracts from C. neofonnans grown for 16 h in the presence of itraconazole (Fig. 3 and 4) . DISCUSSION As in other pathogenic fungi, the major sterol synthesized by C. neofornans is ergosterol. C. neoformans also shares with other pathogenic fungi the sensitivity of its cytochrome P-450-dependent 14a-demethylase to nanomolar concentrations of itraconazole. Indeed, incubation in the presence of itraconazole results in a decreased ergosterol synthesis coinciding with an accumulation of 14- methylglutaryl-coenzyme A reductase as has been described for, e.g., 24,25-epoxidocholesterol (15) . As with A. fumigatus (19) , H. capsulatum (20) , and Malassezia ovale (23) , itraconazole induces the accumulation of large amounts of eburicol. Membrane integrity requires the inserted sterol component to lack C-4 methyl groups (10) . Thus, an accumulation of eburicol will adversely affect the growth of C neoformans since its two methyl groups at C-4 will grossly perturb membrane function. Although eburicol was a predominant sterol found in itraconazole-treated C. neoformans, it still represented only about a quarter of all the sterols extracted from treated cells, a situation quite different from that of M. ovale, which accumulated eburicol almost exclusively when exposed to itraconazole (23) .
Obtusifolione was quantitatively the major sterol found in itraconazole-treated C. neofornans; the effects of the antifungal agent on this yeast therefore resemble those previously observed with H. capsulatum (20) . Prerequisites for both the condensing and liquefying effects of sterols in membranes are a planar ring system and a long flexible chain at C-17 (8) . For sterols to function in the lipid layer of membranes there is also a requirement that the polar group at C-3 act as a H donor in hydrogen bonding with the ester carbonyl moiety of the fatty acid associated with the phospholipid, directly or by way of a water bridge (10) . The studies of Nes et al. prove that the ,-OH group at C-3 is essential for activity and cannot be replaced by a keto group (10) . Furthermore, 3-ketosteroids have been shown to destabilize the lipid bilayer structure and to inhibit the growth of sterol-requiring mycoplasmas (3) . When incorporated in erythrocytes, they greatly increased the permeability and fragility of the membranes (3) . Therefore, the itraconazoleinduced accumulation of obtusifolione and eburicol in C.
neoforinans (this study) and in the yeast form of H. capsulatum (20) may explain the high sensitivity of both yeasts to itraconazole. Indeed, 50% inhibition of growth is achieved at concentrations as low as 3.2 nM (this study) and 1.7 nM (20) , respectively.
Preliminary results indicate that obtusifolione (approximately 18% at 500 nM) and eburicol (approximately 27%) also accumulate inA. fumigatus (unpublished results), with 14a-methyl-ergosta-8,24(28)-dien-33-6a-diol (3,6-diol), obtusifoliol and 14a-methylfecosterol appearing in similar (3,6-diol) or lower concentrations (19) . Obtusifolione and eburicol (see above) and the 3,6-diol (5) are unable to support normal growth. The 3,6-diol is unable to sustain growth even in the presence of ergosterol (5) . Nevertheless, compared with C. neoformans, itraconazole concentrations almost six times higher are required to reach 50% growth inhibition (19) . In contrast with C. neoformans treated with 100 nM itraconazole, A. fumigatus grown in the presence of 500 nM itraconazole still synthesizes trace amounts of ergosterol and accumulates 14a-methylfecosterol (19) . The latter 4,4-demethylated sterol is believed to be functional in fungal membranes (11) . It can satisfy bulk membrane requirements (14, 16) . The trace amounts of ergosterol synthesized by A. fumigatus may fulfill the highly specific roles of ergosterol, i.e., the sparking and/or critical domain function. The absence of both sterols in itraconazole-treated C. neoformans together with the accumulation of obtusifolione and eburicol may be at the origin of itraconazole's greater potency against this yeast.
The accumulation of both eburicol and obtusifolione proves that itraconazole is an inhibitor of the 14a-demethylase; accumulation of the 3-ketosteroid indicates thiat the antifungal agent also interferes with the last step in the demethylation at C-4. The rerTnoval of the first methyl group requires NADPH, molecular oxygen, a cyanide-sensitive factor, and cytochrome b5. The first intermediate formed is a C-4 alcohol that is oxidized to a C-4 aldehyde and further to 4a-carboxy-4,-methyl-3-ketosterol, which is then decarboxylated by a NAD-dependent 4-decarboxylase to yield the 4a-methyl-3-ketosteroid obtusifolione. The final step is the Our studies do not permit the conclusion that itraconazole acts directly on the 3-ketosteroid reductase or that the inhibition observed is secondary to its interaction with the cytochrome P450-dependent demethylase. Indeed, it is possible that 14a-methylated sterols have a lower affinity for the reductase. This is at the moment under investigation. However, regardless of the outcome of the latter study, the results presented here indicate that the growth-inhibitory effect of itraconazole on C. neoformans is the result of an interaction with both the cytochrome P450-dependent 14a-demethylase and the NADPH-dependent 3-ketosteroid reductase. This combined effect completely blocks not only ergosterol synthesis but also that 4,4-demethylated 14a-methylsterols that may otherwise function partly as ergosterol surrogates.
